Regulation of PPARγ2 Stability and Activity by SHP-1

References

• Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA. 1992;89:1123–1127. doi:10.1073/pnas.89.3.1123.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Katagiri T, Hasegawa K, Ogimoto M, Yakura H. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells. J Exp Med. 1996;184:457–463. doi:10.1084/jem.184.2.457.
   PubMed Web of Science ®Google Scholar
• Paling NRD, Welham MJ. Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis. Blood. 2005;105:4290–4297. doi:10.1182/blood-2004-08-3271.
   PubMed Web of Science ®Google Scholar
• Garg M, Wahid M, Khan F. Regulation of peripheral and central immunity: understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2. Immunobiology. 2020;225:151847. doi:10.1016/j.imbio.2019.09.006.
   PubMed Web of Science ®Google Scholar
• Duchesne C, Charland S, Asselin C, Nahmias C, Rivard N. Negative regulation of beta-catenin signaling by tyrosine phosphatase SHP-1 in intestinal epithelial cells. J Biol Chem. 2003;278:14274–14283. doi:10.1074/jbc.M300425200.
   PubMed Web of Science ®Google Scholar
• Bergeron S, Dubois M-J, Bellmann K, Schwab M, Larochelle N, Nalbantoglu J, Marette A. Inhibition of the protein tyrosine phosphatase SHP-1 increases glucose uptake in skeletal muscle cells by augmenting insulin receptor signaling and GLUT4 expression. Endocrinology. 2011;152:4581–4588. doi:10.1210/en.2011-1268.
   PubMed Web of Science ®Google Scholar
• Lodeiro M, Alén BO, Mosteiro CS, Beiroa D, Nogueiras R, Theodoropoulou M, Pardo M, Gallego R, Pazos Y, Casanueva FF, et al. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system. Mol Biol Cell. 2011;22:4182–4191. doi:10.1091/mbc.E11-04-0373.
   PubMed Web of Science ®Google Scholar
• Xu E, Charbonneau A, Rolland Y, Bellmann K, Pao L, Siminovitch KA, Neel BG, Beauchemin N, Marette A. Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance. Diabetes. 2012;61:1949–1958. doi:10.2337/db11-1502.
   PubMed Web of Science ®Google Scholar
• Xu E, Forest M-P, Schwab M, Avramoglu RK, St-Amand E, Caron AZ, Bellmann K, Shum M, Voisin G, Paquet M, et al. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. Hepatology. 2014;59:1803–1815. doi:10.1002/hep.26957.
   PubMed Web of Science ®Google Scholar
• Chiang GG, Sefton BM. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J Biol Chem. 2001;276:23173–23178. doi:10.1074/jbc.M101219200.
   PubMed Web of Science ®Google Scholar
• Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Böhmer FD. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J Biol Chem. 1998;273:24839–24846. doi:10.1074/jbc.273.38.24839.
   PubMed Web of Science ®Google Scholar
• Dubois M-J, Bergeron S, Kim H-J, Dombrowski L, Perreault M, Fournès B, Faure R, Olivier M, Beauchemin N, Shulman GI, et al. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med. 2006;12:549–556. doi:10.1038/nm1397.
   PubMed Web of Science ®Google Scholar
• Wang W, Liu L, Song X, Mo Y, Komma C, Bellamy HD, Zhao ZJ, Zhou GW. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation. J Cell Biochem. 2011;112:2062–2071. doi:10.1002/jcb.23125.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shen K, Lu W, Cole PA. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J Biol Chem. 2003;278:4668–4674. doi:10.1074/jbc.M210028200.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu L, He D, Song X, Liang X, Zhao ZJ, Zhou GW. Crystal structure of human protein-tyrosine phosphatase SHP-1. J Biol Chem. 2003;278:6516–6520. doi:10.1074/jbc.M210430200.
   PubMed Web of Science ®Google Scholar
• Bardot O, Aldridge TC, Latruffe N, Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun. 1993;192:37–45. doi:10.1006/bbrc.1993.1378.
   PubMed Web of Science ®Google Scholar
• Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J. 2004;382:239–245. doi:10.1042/BJ20031340.
   PubMed Web of Science ®Google Scholar
• Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Børgesen M, Francoijs K-J, Mandrup S, et al. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 2008;22:2953–2967. doi:10.1101/gad.501108.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 1997;94:4318–4323. doi:10.1073/pnas.94.9.4318.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. 1995 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 1995;83:813–819. doi:10.1016/0092-8674(95)90194-9.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995;270:12953–12956. doi:10.1074/jbc.270.22.12953.
   PubMed Web of Science ®Google Scholar
• Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest Anim Endocrinol. 2002;22:1–23. doi:10.1016/s0739-7240(01)00117-5.
   PubMed Web of Science ®Google Scholar
• Wu D, Eeda V, Undi RB, Mann S, Stout M, Lim H-Y, Wang W. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice. Mol Metab. 2021;54:101363. doi:10.1016/j.molmet.2021.101363.
   PubMedGoogle Scholar
• Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 1996;274:2100–2103. doi:10.1126/science.274.5295.2100.
   PubMed Web of Science ®Google Scholar
• Choi S, Jung J-E, Yang YR, Kim E-S, Jang H-J, Kim E-K, Kim IS, Lee J-Y, Kim JK, Seo JK, et al. Novel phosphorylation of PPARγ ameliorates obesity-induced adipose tissue inflammation and improves insulin sensitivity. Cell Signal. 2015;27:2488–2495. doi:10.1016/j.cellsig.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Floyd ZE, Stephens JM. Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. Obes Res. 2004;12:921–928. doi:10.1038/oby.2004.112.
   PubMedGoogle Scholar
• Ohshima T, Koga H, Shimotohno K. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. J Biol Chem. 2004;279:29551–29557. doi:10.1074/jbc.M403866200.
   PubMed Web of Science ®Google Scholar
• Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 2005;437:759–763. doi:10.1038/nature03988.
   PubMed Web of Science ®Google Scholar
• Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, Spiegelman BM. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J Biol Chem. 2000;275:18527–18533. doi:10.1074/jbc.M001297200.
   PubMed Web of Science ®Google Scholar
• Floyd ZE, Stephens JM. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J Biol Chem. 2002;277:4062–4068. doi:10.1074/jbc.M108473200.
   PubMed Web of Science ®Google Scholar
• Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293–302. doi:10.1016/j.tem.2014.04.001.
   PubMed Web of Science ®Google Scholar
• Toobian D, Ghosh P, Katkar GD. Parsing the Role of PPARs in Macrophage Processes. Front Immunol. 2021;12:783780. doi:10.3389/fimmu.2021.783780.
   PubMed Web of Science ®Google Scholar
• Lehrke M, Lazar MA. The many faces of PPARgamma. Cell. 2005;123:993–999. doi:10.1016/j.cell.2005.11.026.
   PubMed Web of Science ®Google Scholar
• Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4:263–273. doi:10.1016/j.cmet.2006.07.001.
   PubMed Web of Science ®Google Scholar
• Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, Yamano S, Gonzalez FJ. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 2008;7:302–311. doi:10.1016/j.cmet.2008.03.003.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Shiraishi S, Kishimoto K, Miura S, Ezaki O. An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. J Nutr Biochem. 2011;22:543–553. doi:10.1016/j.jnutbio.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Keshet R, Bryansker Kraitshtein Z, Shanzer M, Adler J, Reuven N, Shaul Y. c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2. Proc Natl Acad Sci USA. 2014;111:16365–16370. doi:10.1073/pnas.1411086111.
   PubMed Web of Science ®Google Scholar
• Zhou X, Gallazzini M, Burg MB, Ferraris JD. Contribution of SHP-1 protein tyrosine phosphatase to osmotic regulation of the transcription factor TonEBP/OREBP. Proc Natl Acad Sci USA. 2010;107:7072–7077. doi:10.1073/pnas.1002795107.
   PubMed Web of Science ®Google Scholar
• Simoneau M, Coulombe G, Vandal G, Vézina A, Rivard N. SHP-1 inhibits β-catenin function by inducing its degradation and interfering with its association with TATA-binding protein. Cell Signal. 2011;23:269–279. doi:10.1016/j.cellsig.2010.09.011.
   PubMed Web of Science ®Google Scholar
• Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J Neurosci. 2012;32:2582–2587. doi:10.1523/JNEUROSCI.5057-11.2012.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med. 1999;189:1815–1822. doi:10.1084/jem.189.11.1815.
   PubMed Web of Science ®Google Scholar
• Burns KA, Vanden Heuvel JP. Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta. 2007;1771:952–960. doi:10.1016/j.bbalip.2007.04.018.
   PubMed Web of Science ®Google Scholar
• Blanquart C, Mansouri R, Fruchart J-C, Staels B, Glineur C. Different ways to regulate the PPARalpha stability. Biochem Biophys Res Commun. 2004;319:663–670. doi:10.1016/j.bbrc.2004.05.035.
   PubMed Web of Science ®Google Scholar
• Kim J-H, Park KW, Lee E-W, Jang W-S, Seo J, Shin S, Hwang K-A, Song J. Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation. Cell Death Differ. 2014;21:594–603. doi:10.1038/cdd.2013.181.
   PubMed Web of Science ®Google Scholar
• Li JJ, Wang R, Lama R, Wang X, Floyd ZE, Park EA, Liao F-F. Ubiquitin ligase NEDD4 regulates PPARγ stability and adipocyte differentiation in 3T3-L1 cells. Sci Rep. 2016;6:38550. doi:10.1038/srep38550.
   PubMed Web of Science ®Google Scholar
• Lee JM, Choi SS, Lee YH, Khim KW, Yoon S, Kim B-G, Nam D, Suh P-G, Myung K, Choi JH. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ. Exp Mol Med. 2018;50:1–11. doi:10.1038/s12276-018-0162-6.
   Web of Science ®Google Scholar
• Xiao Y, Qiao G, Tang J, Tang R, Guo H, Warwar S, Langdon WY, Tao L, Zhang J. Protein tyrosine phosphatase SHP-1 modulates T cell responses by controlling Cbl-b degradation. J Immunol. 2015;195:4218–4227. doi:10.4049/jimmunol.1501200.
   PubMed Web of Science ®Google Scholar
• Kumar A, Schwab M, Laborit Labrada B, Silveira MAD, Goudreault M, Fournier É, Bellmann K, Beauchemin N, Gingras A-C, Bilodeau S, et al. SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis. J Biol Chem. 2023;299:105164. doi:10.1016/j.jbc.2023.105164.
   PubMed Web of Science ®Google Scholar
• Dallaire P, Bellmann K, Laplante M, Gélinas S, Centeno-Baez C, Penfornis P, Peyot M-L, Latour MG, Lamontagne J, Trujillo ME, et al. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes. 2008;57:1999–2011. doi:10.2337/db08-0540.
   PubMed Web of Science ®Google Scholar
• Cribbs AP, Kennedy A, Gregory B, Brennan FM. Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells. BMC Biotechnol. 2013;13:98. doi:10.1186/1472-6750-13-98.
   PubMed Web of Science ®Google Scholar
• Frank C, Burkhardt C, Imhof D, Ringel J, Zschörnig O, Wieligmann K, Zacharias M, Böhmer F-D. Effective dephosphorylation of Src substrates by SHP-1. J Biol Chem. 2004;279:11375–11383. doi:10.1074/jbc.M309096200.
   PubMed Web of Science ®Google Scholar
• Bossé Y, Lamontagne M, Gaudreault N, Racine C, Levesque M-H, Smith BM, Auger D, Clemenceau A, Paré M-È, Laviolette L, et al. Early-onset emphysema in a large French-Canadian family: a genetic investigation. Lancet Respir Med. 2019;7:427–436. doi:10.1016/S2213-2600(19)30056-6.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar